Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Supreme Cannabis Company Inc. (The) T.FIRE

Consumer Cyclical Healthcare Advertising Agencies Drug Manufacturers - Major
The Supreme Cannabis Co Inc is a Canada-based company engaged in the production and sale of medical and recreational cannabis. Its portfolio includes products that address recreational, medical, and wellness consumers. Its brands include BlissCo, Truverra, 7ACRES, Sugarleaf, and Hiway.


TSX:FIRE - Post by User

Supreme Cannabis Company Inc. (The) > BNN
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(48)
•••
Post by Buggered123on Feb 13, 2021 7:14am
450 Views
Post# 32561024

BNN

BNN
Supreme Cannabis notches profitable quarter, $18M in Q2 sales
Supreme Cannabis reported second-quarter results on Thursday, posting a rare profit that gave some analysts hope that it can generate positive free cash flow in its next fiscal quarter. Supreme said its revenue in the second quarter was $18 million, while it booked $3.6 million in adjusted EBITDA. BMO Capital Markets analyst Tamy Chen said in a report to clients that sales of Supreme's premium offerings may suggest that cannabis prices are beginning to stabilize, a sign that the move to value-focused products may have run out of steam

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities